IMCR
Immunocore Holdings plc
32.40
1 x 23.21
2 x 40.96
bid
ask
+
0.75
2.35%
10:19 AM
timesize
| Ytd | -6.67% | |
| 1y | -1.08% |
31.54
day range
32.54
27.55
52 week range
40.72
| Open | 32.42 | Prev Close | 31.65 | Low | 31.54 | High | 32.54 | Mkt Cap | 1.65B |
| Vol | 182.86K | Avg Vol | 460.97K | EPS | -0.56 | P/E | N/A | Forward P/E | -50.80 |
| Beta | 0.75 | Short Ratio | 21.10 | Inst. Own | 104.57% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 29.14 | 200-d Avg | 32.53 | 1yr Est | 63.49 |
| Income Statement | |||
| Total Revenue | 106.68M | ||
| Revenues (USD) | 106.68M | ||
| Cost of Revenue | 434.00K | ||
| Gross Profit | 106.24M | ||
| Operating Expenses | 98.96M | ||
| Research and Development Expense | 61.11M | ||
| Selling, General and Administrative Expense | 37.85M | ||
| Operating Income | 7.28M | ||
| Interest Expense | 3.05M | ||
| Income Tax Expense | 301.00K | ||
| Net Income | 12.97M | ||
| Net Income Common Stock | 12.97M | ||
| Net Income Common Stock (USD) | 12.97M | ||
| Consolidated Income | 12.97M | ||
| Earnings per Basic Share | 0.26 | ||
| Earnings per Basic Share (USD) | 0.26 | ||
| Earnings per Diluted Share | 0.25 | ||
| Earning Before Interest & Taxes (EBIT) | 16.32M | ||
| Earning Before Interest & Taxes (USD) | 16.32M | ||
| Weighted Average Shares | 50.75M | ||
| Weighted Average Shares Diluted | 52.93M | ||
| Balance Sheet | |||
| Cash and Equivalents | 452.68M | ||
| Cash and Equivalents (USD) | 452.68M | ||
| Investments | 392.22M | ||
| Investments Current | 392.22M | ||
| Trade and Non-Trade Receivables | 81.07M | ||
| Current Assets | 1.00B | ||
| Property, Plant & Equipment Net | 49.67M | ||
| Total Assets | 1.07B | ||
| Debt Current | 2.00M | ||
| Total Debt | 435.68M | ||
| Current Liabilities | 240.11M | ||
| Debt Non-Current | 433.69M | ||
| Total Liabilities | 678.42M | ||
| Accumulated Retained Earnings (Deficit) | -818.30M | ||
| Accumulated Other Comprehensive Income | -35.37M | ||
| Shareholders Equity | 393.67M | ||
| Shareholders Equity (USD) | 393.67M | ||
| Assets Non-Current | 68.29M | ||
| Total Debt (USD) | 435.68M | ||
| Deferred Revenue | 5.19M | ||
| Inventory | 8.25M | ||
| Liabilities Non-Current | 438.31M | ||
| Trade and Non-Trade Payables | 30.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.58M | ||
| Net Cash Flow from Financing | 656.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.90M | ||
| Capital Expenditure | -1.78M | ||
| Issuance (Purchase) of Equity Shares | 656.00K | ||
| Net Cash Flow from Investing | 4.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.00M | ||
| Net Cash Flow from Operations | -13.77M | ||
| Share Based Compensation | 6.30M | ||